Allergan works toward blockbuster goal with new jawline approval for CoolSculpting | Fierce Pharma
Allergan takes its female empowerment message where pharma rarely goes: tank tops | Fierce Pharma
Allergan's €42m investment boosts Irish manufacturing and jobs
Allergan pulls Biocell breast implants due to cancer risk | The Standard
Allergan textured breast implants pulled from the US market
Botox Rivals Create New Wrinkles for Allergan - WSJ
Allergan Aesthetics | An AbbVie Company
Allergan embraces growth pharma model, accelerates business with the Microsoft 365 Enterprise | Microsoft 365 Blog
Allergan Pulls Textured Breast Implant Following FDA Request | RAPS
After investor attacks, Allergan's reviewing 'all options'—and this time it's urgent, CEO says | Fierce Pharma
Biocell breast implants pulled from sale in Canada | CBC News
Allergan gets a lift from assessment that threat to Botox is overblown | Fierce Pharma
Allergan Aesthetics | An AbbVie Company
Allergan pulls plug on $200 million expansion
AbbVie buys Allergan in $63B pharmaceutical acquisition
Allergan CEO's pay and stock gains: $57.7M
Allergan Pharmaceutical Lacri-Lube Lubricant Eye Ointment
/https://www.thestar.com/content/dam/thestar/news/investigations/2019/07/24/allergan-breast-implants-linked-to-rare-cancer-pulled-in-global-recall/biocell.jpg "Allergan breast implants linked to rare cancer pulled in global recall | The Star")
Allergan breast implants linked to rare cancer pulled in global recall | The Star
Allergan pulls breast implants after link to rare cancer -
Amazon.com: Allergan Refresh Plus Eye Drops, Lubricant, Sensitive, 50 ct. : Health & Household
Allergan pulls plug on $200 million expansion
